ArticleJournal of immunology research2022

Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer.

Yinan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.